We are live on
!
Find out more
HI
Human Investing Portfolio holdings
AUM
$771M
1-Year Est. Return
18.84%
This Fund
S&P 500
This Quarter
Est. Return
-3.3%
1 Year Est. Return
+18.84%
3 Year Est. Return
+51.96%
5 Year Est. Return
+53.41%
10 Year Est. Return
–
AUM
$429M
AUM Growth
-$8.8M
(-2%)
Cap. Flow
+$6.8M
Cap. Flow
% of AUM
1.58%
Top 10 Holdings %
Top 10 Hldgs %
70.05%
Holding
103
New
4
Increased
31
Reduced
54
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.09M |
| 2 |
Vanguard ESG US Stock ETF
ESGV
|
+$1.54M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.11M |
| 4 |
Amgen
AMGN
|
+$511K |
| 5 |
Microsoft
MSFT
|
+$496K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$581K |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$372K |
| 3 |
Apple
AAPL
|
+$358K |
| 4 |
Lamb Weston
LW
|
+$262K |
| 5 |
K
Kellanova
K
|
+$240K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4% |
| 2 | Healthcare | 2.96% |
| 3 | Consumer Discretionary | 2.35% |
| 4 | Consumer Staples | 0.79% |
| 5 | Communication Services | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard S&P 500 ETF
VOO
$979B
| $104M | 24.13% |
263,877
+7,567
| +3% | +$3.09M |
|
|
2
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $42M | 9.78% |
960,442
+24,321
| +3% | +$1.11M |
|
3
Vanguard Short-Term Bond ETF
BSV
$44.7B
| $24.4M | 5.68% |
324,292
+3,480
| +1% | +$262K |
|
4
Vanguard Dividend Appreciation ETF
VIG
$111B
| $24.2M | 5.63% |
155,619
+1,909
| +1% | +$309K |
|
5
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $23.2M | 5.4% |
224,455
+3,055
| +1% | +$328K |
|
6
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $21.9M | 5.1% |
439,110
+8,855
| +2% | +$464K |
|
7
Vanguard Total International Bond ETF
BNDX
$81.9B
| $19.5M | 4.55% |
408,258
+6,727
| +2% | +$326K |
|
|
8
iShares Core S&P 500 ETF
IVV
$878B
| $17M | 3.96% |
39,591
-832
| -2% | -$372K |
|
9
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $13.2M | 3.08% |
183,157
+3,471
| +2% | +$257K |
|
10
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $11.8M | 2.74% |
204,253
+4,106
| +2% | +$237K |
|
11
iShares Core S&P Small-Cap ETF
IJR
$109B
| $11.4M | 2.66% |
121,182
+2,050
| +2% | +$205K |
|
12
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $10.7M | 2.5% |
273,513
+6,629
| +2% | +$271K |
|
13
Vanguard International High Dividend Yield ETF
VYMI
$20.6B
| $9.65M | 2.25% |
155,890
+332
| +0.2% | +$21.1K |
|
|
14
Vanguard ESG US Stock ETF
ESGV
$13.1B
| $9.28M | 2.16% |
123,408
+19,645
| +19% | +$1.54M |
|
15
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
| $9.25M | 2.15% |
129,697
+80
| +0.1% | +$5.95K |
|
16
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $4.58M | 1.07% |
21,553
+692
| +3% | +$153K |
|
17
Vanguard Real Estate ETF
VNQ
$39.2B
| $3.85M | 0.9% |
50,854
-480
| -0.9% | -$39.6K |
|
|
18
Apple
AAPL
$4.54T
| $3.82M | 0.89% |
22,322
-1,950
| -8% | -$358K |
|
19
Nike
NKE
$61.9B
| $3.71M | 0.86% |
38,775
-14
| -0% | -$1.44K |
|
20
Vanguard ESG International Stock ETF
VSGX
$6.52B
| $3.48M | 0.81% |
69,037
+5,842
| +9% | +$308K |
|
21
Broadcom
AVGO
$1.85T
| $2.94M | 0.68% |
35,390
-1,240
| -3% | -$107K |
|
22
Vanguard ESG US Corporate Bond ETF
VCEB
$1.18B
| $2.57M | 0.6% |
43,334
+5,302
| +14% | +$323K |
|
|
23
Microsoft
MSFT
$3.45T
| $2.51M | 0.58% |
7,952
+1,501
| +23% | +$496K |
|
24
AbbVie
ABBV
$443B
| $2.32M | 0.54% |
15,586
+57
| +0.4% | +$8.37K |
|
|
NVO
25
Novo Nordisk
NVO
$208B
| $2.29M | 0.53% |
25,198
-334
| -1% | -$29.4K |
|
Similar funds
WI
CCA
PGA
SC
PA
BPIM
TCM
PC
Human Investing's Q3 2023 Portfolio in Review
As of Q3 2023, Human Investing held 103 positions worth $429M, down 2% from $438M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Human Investing's Q3 2023 filing shows 4 new, 31 increased, 54 reduced and 8 closed positions. Its largest new stake was Thermo Fisher Scientific: 704 shares worth $356K. The largest sale was Merck, an estimated $581K.
By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 4.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Human Investing's largest Q3 2023 buy was Thermo Fisher Scientific: 704 shares worth $356K.
- Human Investing added most to Vanguard S&P 500 ETF in Q3 2023, an estimated $3.09M increase.
- Human Investing's biggest Q3 2023 reduction was Merck, cutting an estimated $581K.
- Human Investing fully exited Lamb Weston in Q3 2023, selling an estimated $262K.
- Human Investing's ten largest holdings make up 70% of its $429M portfolio in Q3 2023.
- Human Investing opened 4 new positions and closed 8 in Q3 2023.
- Human Investing's portfolio value fell 2% quarter-over-quarter to $429M.
Based on Human Investing's 13F filing for Q3 2023, filed 9 Nov 2023.